Sho Masui, Aoto Nakajima, Kodai Yajima, Takashi Shimada, Akira Onishi, Makoto Okabe et al. Assessment of infliximab biotransformation in patient serum by comparing mass-spectrometry and ligand-binding assay quantification. // Drug Metabolism and Pharmacokinetics. – 2026. – DOI: 10.1016/j.dmpk.2026.101551. – URL: https://doi.org/10.1016/j.dmpk.2026.101551
Sho Masui, Aoto Nakajima, Kodai Yajima, Takashi Shimada, Akira Onishi, Makoto Okabe, Shuji Yamamoto, Tomohiro Terada, & Atsushi Yonezawa (2026). Assessment of infliximab biotransformation in patient serum by comparing mass-spectrometry and ligand-binding assay quantification. Drug Metabolism and Pharmacokinetics. https://doi.org/10.1016/j.dmpk.2026.101551
Sho Masui, et al. “Assessment of infliximab biotransformation in patient serum by comparing mass-spectrometry and ligand-binding assay quantification.” Drug Metabolism and Pharmacokinetics, 2026. doi:10.1016/j.dmpk.2026.101551.
@article{Masui2026,
title = {Assessment of infliximab biotransformation in patient serum by comparing mass-spectrometry and ligand-binding assay quantification},
author = {Masui, Sho and Nakajima, Aoto and Yajima, Kodai and Shimada, Takashi and Onishi, Akira and Okabe, Makoto and Yamamoto, Shuji and Terada, Tomohiro and Yonezawa, Atsushi},
journal = {Drug Metabolism and Pharmacokinetics},
year = {2026},
doi = {10.1016/j.dmpk.2026.101551},
url = {https://doi.org/10.1016/j.dmpk.2026.101551}
}